Instil Bio, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-71.4M | $-74.1M | $-156.1M | $-223.2M | $-156.8M | $-37.7M |
| Depreciation & Amortization | $534.0K | $3.6M | $4.8M | $6.0M | $2.8M | $256.0K |
| Depreciation | $500.0K | $3.6M | $4.8M | $6.0M | $2.7M | $300.0K |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $8.7M | $17.3M | $18.2M | $30.4M | $26.2M | $1.7M |
| Net Cash from Operating Activities | $-36.6M | $-55.7M | $-82.0M | $-180.2M | $-122.1M | $-29.6M |
| Investing Activities | ||||||
| Capital Expenditures | — | $0 | $20.7M | $84.6M | $57.8M | $50.8M |
| Business Acquisitions | — | — | — | — | $0 | $306.0K |
| Net Cash from Investing Activities | $25.5M | $54.0M | $41.1M | $114.5M | $-474.4M | $-51.1M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $7.3M | $1.8M | $8.1M | $71.9M | $393.2M | $313.0M |
| Net Change in Cash | — | — | — | — | — | — |
| Free Cash Flow | — | $-55.7M | $-102.7M | $-264.8M | $-180.0M | $-80.4M |